Jump to ContentJump to Main Navigation
Oxford Textbook of Medicine$
Users without a subscription are not able to see the full content.

Edited by David A. Warrell, Timothy M. Cox, John D. Firth

Online access to the Oxford Textbook of Medicine in low and middle income countries is available through the World Health Organization-led HINARI Access to Research in Health programme

Latest update

The May 2013 update sees updates to chapters focusing on Respiratory Medicine and Haematology.

Respiratory Medicine updates include substantial updates to key chapters and new material on a wide range of topics including: new bronchoscopic techniques for early detection of lung cancer, specific causes of effusion and pleural disease, and chronic obstructive pulmonary disease.

Haematology updates include extensive revisions of key chapters on chronic myeloid leukaemia, aplastic anaemia and bone marrow failure disorders, and blood transfusion, with new information on a wide range of matters.

Access token activation

If you have an access token, please click here to activate it.

Sign up for an individual subscription to the Oxford Textbook of Medicine.

Subscriber Login

Forgotten your password?

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Contents

Typhoid and paratyphoid fevers

Chapter:
Typhoid and paratyphoid fevers
Author(s):

C.M. Parry,

Buddha Basnyat

DOI:
10.1093/med/9780199204854.003.070608_update_002

May 30, 2013: This chapter has been re-evaluated and remains up-to-date. No changes have been necessary.

Update:

Changes in nomenclature.

Similiarity between clinical presentation of S. Typhi and S. Paratyphi.

Update on diagnostic tests.

Updated on 31 May 2012. The previous version of this content can be found here.

Typhoid and paratyphoid fever (the enteric fevers) are caused by specific serovars of the Gram-negative bacillus, Salmonella enterica. Sources of typhoid transmission are excreting chronic or convalescent carriers and the acutely infected, with transmission occuring through contamination by carriers of food or water by effluents containing infected urine or faeces. There are an estimated 27 million cases of enteric fever in the world each year, almost all in the developing world, with about 200 000 deaths.

Clinical features—the main symptom is fever (39–40° C); headache and malaise are common; constipation is a frequent early symptom, but most patients will experience diarrhoea; abdominal pain is usually diffuse and poorly localized. Physical examination is often unremarkable, apart from fever, but rose spots and relative bradycardia may be observed. In developing countries, patients may progress in the second to fourth week, with life-threatening manifestations including gastrointestinal bleeding, intestinal perforation, and the syndrome of mental confusion.

Diagnosis—the principal method for confirming the diagnosis is by isolating Salmonella Typhi or Salmonella Paratyphi from blood or bone marrow. The organisms may also be isolated from stool, urine, and bile aspirates, but such demonstration should be interpreted with caution in areas with many chronic carriers as the acute illness may be due to another cause.

Treatment—aside from supportive care, antibiotic therapy reduces mortality and complications and shortens the illness. Antibiotic resistance is a common and increasing problem, hence the choice of antibiotic should be informed by knowledge of likely local susceptibility. Fluoroquinolones are often given as first-line treatment, although low-level resistance to these agents (marked by nalidixic acid resistance) is widespread in Asia, with extended-spectrum cephalosporins and azithromycin as alternatives.

Prevention—typhoid has been eliminated from industrialized countries by (1) the provision of safe drinking water and safe disposal of sewage; (2) legal enforcement of high standards of food hygiene, and programmes to detect, monitor, and treat chronic carriers; and (3) prompt investigation and intervention when these safeguards are breached. Measures for individual protection are to (1) kill the organism in water by heating to 57° C, iodination, or chlorination; (2) take care with uncooked or reheated food; and (3) immunization—two typhoid vaccines are available and widely used in travellers, but their role as a public health tool in endemic areas is undefined; there is no paratyphoid vaccine.

Oxford Medicine requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us.